As the majority of patients with T2DM are also obese, medications that exacerbate weight gain are not ideal
Mechanism of action Cagrilintide is modified amylin: natural 37 amino acid sequence + conjugated C20-fatty acid via linker (like semaglutide) plasma albumin binding half-life extension from 12 min to ~7 days weekly dosing
Nat Commun 15 , 5912 (2024)
NHS-commissioned semaglutide 2.4mg (Wegovy) for obesity is restricted to specialist weight management services with a maximum treatment duration of two years
Although several pieces of data suggest a possible therapeutic effect of GSH, administered directly or through its precursor N-Acetil Cystein (NAC), in drug-induced liver disease (DILI) [112,113], no randomized-controlled clinical trials are available to support this evidence
These preclinical and clinical data will be helpful to deconvolute the risk profiles for ADE versus other known severe adverse events that can occur with human CP, including transfusion-related acute lung injury 96,100